Alexion Pharma (ALXN)

105.89 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/4/20 *Est.)
- M&A (6/30/20 *Est)
- Conference (11/19/2019)

Latest Headlines

Alexion to Present at the 2019 Stifel Healthcare Conference November 13, 2019 6:30 AM - BizWire Fortress Biotech Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights November 12, 2019 7:30 AM - StreetInsider UPDATE: SunTrust Starts Alexion Pharmaceuticals (ALXN) at Buy; Stock Discounting Risks While Pipeline Underappreciated November 12, 2019 4:31 AM - StreetInsider Alexion Announces Data Presentations at 61st American Society of Hematology Annual Meeting November 6, 2019 10:30 AM - BizWire Form 3 ALEXION PHARMACEUTICALS, For: Nov 04 Filed by: Carino Tanisha November 5, 2019 4:44 PM - SEC Filing Alexion Pharmaceuticals (ALXN) PT Lowered to $150 at Oppenheimer October 24, 2019 9:25 AM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $170 at Raymond James October 24, 2019 7:52 AM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Raised to $149 at Wedbush October 23, 2019 1:51 PM - StreetInsider Form 10-Q ALEXION PHARMACEUTICALS, For: Sep 30 October 23, 2019 7:58 AM - SEC Filing Form 8-K ALEXION PHARMACEUTICALS, For: Oct 23 October 23, 2019 7:14 AM - SEC Filing Alexion Pharma (ALXN) Tops Q3 EPS by 32c, Raises FY Guidance October 23, 2019 6:35 AM - StreetInsider Alexion Reports Third Quarter 2019 Results October 23, 2019 6:30 AM - BizWire Form 8-K ALEXION PHARMACEUTICALS, For: Oct 21 October 21, 2019 5:28 PM - SEC Filing Alexion Pharma (ALXN) Receives FDA Approval for ULTOMIRIS for aHUS October 21, 2019 6:23 AM - StreetInsider Alexion Receives FDA Approval for ULTOMIRIS® (ravulizumab-cwvz) for Atypical Hemolytic Uremic Syndrome (aHUS) October 18, 2019 7:45 PM - BizWire BofA/Merrill Lynch Reinstates Alexion Pharmaceuticals (ALXN) at Buy October 17, 2019 6:43 AM - StreetInsider Alexion Pharmaceuticals (ALXN) PT Lowered to $120 at Jefferies October 16, 2019 2:14 PM - StreetInsider Wedbush Positive on Alexion (ALXN) Amid Achillion Acquisition October 16, 2019 10:17 AM - StreetInsider Pre-Open Movers 10/16: (ACHN) (TECD) (SNBR) Higher; (PRQR) (RYTM) (WDAY) Lower (more...) October 16, 2019 9:25 AM - StreetInsider Form DEFA14A ALEXION PHARMACEUTICALS, October 16, 2019 8:54 AM - SEC Filing Form 8-K ALEXION PHARMACEUTICALS, For: Oct 15 October 16, 2019 8:51 AM - SEC Filing Alexion Pharmaceuticals (ALXN) Reiterated Buy at Nomura but EPS Expected to be Below Consensus October 16, 2019 6:35 AM - StreetInsider Alexion (ALXN) to Acquire Achillion (ACHN) for Initial Consideration of $6.30/Share in $930 Million Deal October 16, 2019 6:31 AM - StreetInsider Alexion to Acquire Achillion October 16, 2019 6:30 AM - BizWire Alexion Pharmaceuticals (ALXN) PT Lowered to $170 at Morgan Stanley October 11, 2019 8:44 AM - StreetInsider Alexion Announces Appointment of Tanisha Carino, Ph.D., as Chief Corporate Affairs Officer October 10, 2019 4:01 PM - BizWire Alexion (ALXN), Stealth (MITO) Announce Agreement for Option to Co-Develop and Commercialize Late-Stage Therapy for Mitochondrial Diseases October 10, 2019 7:31 AM - StreetInsider Alexion and Stealth Announce Agreement for Option to Co-Develop and Commercialize Late-Stage Therapy for Mitochondrial Diseases October 10, 2019 7:30 AM - BizWire Alexion to Report Third Quarter 2019 Results On Wednesday, October 23, 2019 October 8, 2019 4:01 PM - BizWire William Blair Starts Alexion Pharmaceuticals (ALXN) at Outperform September 26, 2019 6:03 AM - StreetInsider Alexion Pharmaceuticals (ALXN) CFO Successor Is A Strong Replacement - RBC September 18, 2019 8:27 AM - StreetInsider Form 8-K ALEXION PHARMACEUTICALS, For: Sep 17 September 17, 2019 4:13 PM - SEC Filing Alexion Pharma (ALXN) Reports CFO Succession September 17, 2019 4:01 PM - StreetInsider Alexion Announces CFO Succession September 17, 2019 4:01 PM - BizWire BMO Capital Starts Alexion Pharmaceuticals (ALXN) at Outperform September 12, 2019 2:57 AM - StreetInsider Alexion Pharma (ALXN), BridgeBio Pharma (BBIO) Reports License Agreement for Eidos’ (EIDX) Transthyretin Amyloidosis (ATTR) Investigational Medicine September 9, 2019 7:32 AM - StreetInsider Alexion and BridgeBio Announce Japanese License Agreement for Eidos’ Transthyretin Amyloidosis (ATTR) Investigational Medicine September 9, 2019 7:30 AM - BizWire Alexion Pharma (ALXN) reports European Patent Office determined not to grant patent applications 3124029 and 3167888 September 5, 2019 5:05 PM - StreetInsider Form 8-K ALEXION PHARMACEUTICALS, For: Sep 05 September 5, 2019 5:02 PM - SEC Filing Alexion Pharmaceuticals (ALXN) PT Raised to $161 at SVB Leerink September 5, 2019 7:26 AM - StreetInsider Alexion to Present at the 17th Annual Morgan Stanley Global Healthcare Conference September 4, 2019 6:30 AM - BizWire Alexion Pharmaceuticals (ALXN) PT Lowered to $157 at SVB Leerink September 3, 2019 6:31 AM - StreetInsider Stifel Reiterates Hold Rating on Alexion Pharmaceuticals (ALXN) August 30, 2019 12:14 PM - StreetInsider Citi Is Buyer on Weakness in Alexion Pharmaceuticals (ALXN), Sees Fair Value around $131-$133 August 30, 2019 12:00 PM - StreetInsider Alexion (ALXN) Soliris IPR Surprising, But Long-Term Impact 'Limited' - Raymond James August 30, 2019 10:59 AM - StreetInsider Piper Jaffray Defends Alexion Pharmaceuticals (ALXN) August 30, 2019 10:44 AM - StreetInsider Alexion Pharmaceuticals (ALXN) PTAB News an 'Incremental Negative' - Baird August 30, 2019 10:25 AM - StreetInsider Increasing unusual option volume: ALXN COO ULTA DELL AMBA August 30, 2019 10:04 AM - StreetInsider Pre-Open 08/30: (SEAC) (AMBA) (MSGN) Higher (ULTA) (AOBC) (ALXN) Lower (more...) August 30, 2019 9:19 AM - StreetInsider Alexion Pharma (ALXN) Soliris patents get review on Amgen (AMGN) challenge at patent office - Bloomberg August 30, 2019 8:49 AM - StreetInsider Alexion Announces Upcoming Data Presentations at 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis August 28, 2019 8:30 AM - BizWire Alexion to Present at the 14th Annual Citi Biotech Conference August 28, 2019 6:30 AM - BizWire Alexion Pharma's (ALXN) SOLIRIS Granted EC Approval for NMOSD August 27, 2019 8:32 AM - StreetInsider European Commission Approves SOLIRIS® (eculizumab) For the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD) August 27, 2019 8:30 AM - BizWire Pre-Open Movers 08/26: (FBIO) (MDCO) (PBI) Higher (ALXN) (CREE) (AMGN) Lower (more...) August 26, 2019 9:28 AM - StreetInsider Surprise... Amgen (AMGN) Didn't Buy Alexion Pharma (ALXN) August 26, 2019 9:15 AM - StreetInsider Stocks with Implied Volatility Movement August 26, 2019 4:46 AM - StreetInsider Alexion Pharma (ALXN) Takeover By Amgen (AMGN) 'Highly Unlikely' - Cowen August 23, 2019 6:42 AM - StreetInsider Alexion Pharma (ALXN) August weekly calls active August 23, 2019 5:11 AM - StreetInsider Alexion (ALXN) Takeover by Amgen (AMGN) 'Not Likely' - Sources August 22, 2019 3:48 PM - StreetInsider Alexion Pharma (ALXN) option implied volatility elevated as shares rally 8.8% August 22, 2019 3:42 PM - StreetInsider Alexion Pharma (ALXN) Adds to Gains; Shares Up 8% August 22, 2019 1:41 PM - StreetInsider Alexion Pharma (ALXN) Spikes to Highs August 22, 2019 1:03 PM - StreetInsider Alexion Pharma (ALXN) call put ratio 5.7 calls to 1 put with focus on August weekly 117 calls August 22, 2019 12:53 PM - StreetInsider Piper Jaffray Reiterates Overweight Rating on Amgen (AMGN) August 22, 2019 12:45 PM - StreetInsider Amgen (AMGN)/Alexion Pharma (NASDAQ: ALXN) engaged in rather protracted and nasty legal fight over biosimilar Soliris in Europe - Adam Feurstein August 22, 2019 12:00 PM - StreetInsider Alexion Pharma (ALXN)/Amgen (AMGN) Merger 'Not a Crazy Thought' - Mizuho August 22, 2019 10:57 AM - StreetInsider Alexion Pharma (ALXN) Ticks Higher on Renewed Chatter August 21, 2019 1:54 PM - StreetInsider Full Article List